Furthermore, the same authors report that METTL14 levels are reduced in breast cancer and they are associated with low survival rates, suggesting that METTL14 could potentially regulate m6A modification of miRNAs also in this type of tumour [88]. This evidence concerns the gene METTL14 and breast carcinoma.